Pharmaceutical Excipients Market Trends, Growth, Size By 2034

Pharmaceutical Excipients Market Growth, Size, Trends Analysis - By Product, By Functionality, By Formulation - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published: Jun-2019 Report ID: PHAR1911 Pages: 1 - 107 Formats*:     
Category : Pharmaceutical
Pharmaceutical Excipients Market Introduction and Overview 

According to SPER Market Research, the Global Pharmaceutical Excipients Market is estimated to reach USD 21.72 billion by 2034 with a CAGR of 8.23%.

The report includes an in-depth analysis of the Global Pharmaceutical Excipients Market, including market size and trends, product mix, Applications, and supplier analysis. The pharmaceutical excipients market is anticipated to increase at a compound annual growth rate (CAGR) of 8.23% from 2025 to 2034, reaching a valuation of USD 9.85 billion in 2024. The market is likely to be driven by factors such the increasing use of biologics and biopharmaceuticals, such as proteins, peptides, and nucleic acids. Additionally, the market is growing as a result of the growing pharmaceutical industry and increased pharmaceutical production operations.

By Product Insights
The market is divided into three segments: other chemicals, inorganic chemicals, and organic chemicals. In 2024, the market for pharmaceutical excipients with the largest revenue was headed by the organic segment. There is a rising demand for organic excipients from natural sources like plant-based polymers, sugars, and proteins due to consumer preferences for natural products. Pharmaceutical companies are also looking for biodegradable and sustainable excipients, boosting the popularity of organic chemicals like cellulose derivatives and polysaccharides for new drug delivery systems.

By Functionality Insights
The pharmaceutical excipients market is divided into categories based on functionality, including binders, suspension agents, glidants, preservatives, fillers, lubricants, emulsifiers, disintegrants, and others. In 2024, the binder segment had the largest market share. Binders act as adhesives that hold granules, powders, and dry ingredients together, ensuring tablet or capsule shape and preventing ingredient separation. Common binders used are starch, gelatin, PVP, and HPMC.

By Formulation Insights
The market for pharmaceutical excipients is categorised by formulation, including topical, parenteral, liquid, oral, and others. From 2025 to 2034, the oral formulation market is expected to grow at the fastest rate. Patients can easily consume oral forms, such tablets and capsules, which also guarantee precise dosage. Excipients are essential for creating solid dosage forms that are simple to consume and offer regulated release of the active pharmaceutical ingredient (API), which enhances patient adherence.

Regional Insights
North America has a significant revenue share in the pharmaceutical excipients market and is likely to dominate during the forecast period. Factors such as the quickly increasing pharmaceutical sector, increased demand for functional excipients, the existence of major competitors in the region, and technological advancements will all contribute considerably to the market's growth over the forecast period. Furthermore, technologically advanced or superior excipients propel market growth.



Market Competitive Landscape
The pharmaceutical excipients sector has a competitive landscape with established pharmaceutical companies striving for market share. Key players are strengthening their product portfolios through strategic activities such as mergers, acquisitions, and alliances. The companies are aggressively pursuing a multifaceted approach to meet the growing demand for effective pharmaceutical excipients. Key market players are Air Liquide S.A, Archer Daniels Midland Company, Ashland, Associated British Foods PLC, BASF SE, among others.

Recent Developments:

  • Clariant, a speciality chemicals firm focussing on sustainability, announced a portfolio of high-performing pharmaceutical ingredient solutions in October 2023 to help advance the development of safe and effective medications. Clariant Health Care also increased its functional excipient portfolio to address active pharmaceutical ingredient (API) distribution and bioavailability concerns.
  • In September 2023, Roquette, a firm that specialises in plant-based components and supplies pharmaceutical and nutraceutical excipients, introduced three new excipient grades to its line of solutions for active pharmaceutical and nutraceutical compounds that are sensitive to moisture.
 Report Metric Details
 Market size available for years 2021-2034
 Base year considered 2024
 Forecast period 2025-2034
 Segments coveredBy Product, By Functionality, By Formulation
 Regions coveredNorth America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
 Companies Covered
Air Liquide S.A, Archer Daniels Midland Company, Ashland, Associated British Foods PLC, BASF SE, Croda International PLC, Evonik Industries AG, Innophos, Kerry Group plc, Merck KGaA.
Key Topics Covered in the Report
  • Global Pharmaceutical Excipients Market Size (FY’2021-FY’2034)
  • Overview of Global Pharmaceutical Excipients Market
  • Segmentation of Global Pharmaceutical Excipients Market By Product (Organic chemicals, Inorganic chemicals)
  • Segmentation of Global Pharmaceutical Excipients Market By Functionality (Binder, Suspension and viscosity agents, Glidants, Preservatives, Filler & diluent, Lubricant, Emulsifier, Disintegrant, Other functionalities)
  • Segmentation of Global Pharmaceutical Excipients Market By Formulation (Oral, Liquid, Parenteral, Topical, Other Formulations)
  • Statistical Snap of Global Pharmaceutical Excipients Market
  • Expansion Analysis of Global Pharmaceutical Excipients Market
  • Problems and Obstacles in Global Pharmaceutical Excipients Market
  • Competitive Landscape in the Global Pharmaceutical Excipients Market
  • Details on Current Investment in Global Pharmaceutical Excipients Market
  • Competitive Analysis of Global Pharmaceutical Excipients Market
  • Prominent Players in the Global Pharmaceutical Excipients Market
  • SWOT Analysis of Global Pharmaceutical Excipients Market
  • Global Pharmaceutical Excipients Market Future Outlook and Projections (FY’2025-FY’2034)
  • Recommendations from Analyst
1. Introduction
  • 1.1. Scope of the report
  • 1.2. Market segment analysis
2. Research Methodology
  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER’s internal database
    • 2.1.4. Premium insight from KOL’s
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation
3. Executive Summary

4. Market Dynamics
  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
5. Market variable and outlook
  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER’s Five Forces 
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis
6. Competitive Landscape
  • 6.1. Global Pharmaceutical Excipients Market Manufacturing Base Distribution, Sales Area, Product Type 
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Pharmaceutical Excipients Market
7. Global Pharmaceutical Excipients Market, By Product (USD Million) 2021-2034
  • 7.1. Organic chemicals
    • 7.1.1. Oleochemicals
    • 7.1.2. Carbohydrates
    • 7.1.3. Petrochemicals
    • 7.1.4. Proteins
    • 7.1.5. Other organic chemicals
  • 7.2. Inorganic chemicals
    • 7.2.1. Calcium phosphate
    • 7.2.2. Metal oxides
    • 7.2.3. Halites
    • 7.2.4. Calcium carbonate
    • 7.2.5. Calcium sulfate
    • 7.2.6.  Other inorganic chemicals
8. Global Pharmaceutical Excipients Market, By Functionality (USD Million) 2021-2034
  • 8.1. Binder
  • 8.2. Suspension and viscosity agents
  • 8.3. Glidants
  • 8.4. Preservatives
  • 8.5. Filler & diluent
  • 8.6. Lubricant
  • 8.7. Emulsifier
  • 8.8. Disintegrant
  • 8.9. Other functionalities
9. Global Pharmaceutical Excipients Market, By Formulation (USD Million) 2021-2034
  • 9.1. Oral
    • 9.1.1. Tablet
    • 9.1.2. Capsule
    • 9.1.3. Other oral formulations
  • 9.2. Liquid
  • 9.3. Parenteral
  • 9.4. Topical
  • 9.5. Other formulations
10. Global Pharmaceutical Excipients Market, (USD Million) 2021-2034
  • 10.1. Global Pharmaceutical Excipients Market Size and Market Share
11. Global Pharmaceutical Excipients Market, By Region, (USD Million) 2021-2034
  • 11.1. Asia-Pacific
    • 11.1.1. Australia
    • 11.1.2. China
    • 11.1.3. India
    • 11.1.4. Japan
    • 11.1.5. South Korea
    • 11.1.6. Rest of Asia-Pacific
  • 11.2. Europe
    • 11.2.1. France
    • 11.2.2. Germany
    • 11.2.3. Italy
    • 11.2.4. Spain
    • 11.2.5. United Kingdom
    • 11.2.6. Rest of Europe
  • 11.3. Middle East and Africa
    • 11.3.1. Kingdom of Saudi Arabia 
    • 11.3.2. United Arab Emirates
    • 11.3.3. Qatar
    • 11.3.4. South Africa
    • 11.3.5. Egypt
    • 11.3.6. Morocco
    • 11.3.7. Nigeria
    • 11.3.8. Rest of Middle-East and Africa
  • 11.4. North America
    • 11.4.1. Canada
    • 11.4.2. Mexico
    • 11.4.3. United States
  • 11.5. Latin America
    • 11.5.1. Argentina
    • 11.5.2. Brazil
    • 11.5.3. Rest of Latin America 
12. Company Profile
  • 12.1. Air Liquide S.A
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary 
    • 12.1.4. Recent developments
  • 12.2. Archer Daniels Midland Company
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary 
    • 12.2.4. Recent developments
  • 12.3. Ashland
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary 
    • 12.3.4. Recent developments
  • 12.4. Associated British Foods PLC
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary 
    • 12.4.4. Recent developments
  • 12.5. BASF SE
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary 
    • 12.5.4. Recent developments
  • 12.6. Croda International PLC
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary 
    • 12.6.4. Recent developments
  • 12.7. Evonik Industries AG
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary 
    • 12.7.4. Recent developments
  • 12.8. Innophos
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary 
    • 12.8.4. Recent developments
  • 12.9. Kerry Group plc
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary 
    • 12.9.4. Recent developments
  • 12.10. Merck KGaA
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary 
    • 12.10.4. Recent developments
  • 12.11. Others
13. Conclusion

14. List of Abbreviations

15. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
Pharmaceutical Excipients Market is projected to reach USD 21.72 billion by 2034, growing at a CAGR of of 8.23% during the forecast period.
Pharmaceutical Excipients Market grew in Market size from 2025. The Market is expected to reach USD 21.72 billion by 2034, at a CAGR of 8.23% during the forecast period.
Pharmaceutical Excipients Market CAGR of 8.23% during the forecast period.
Pharmaceutical Excipients Market size is USD 21.72 billion from 2025 to 2034.
Pharmaceutical Excipients Market is covered By Product, By Functionality, By Formulation
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Air Liquide S.A, Archer Daniels Midland Company, Ashland, Associated British Foods PLC, BASF SE, Croda International PLC, Evonik Industries AG, Innophos, Kerry Group plc, Merck KGaA.
The report includes an in-depth analysis of the Global Pharmaceutical Excipients Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
  • 15 % off
     
    $ 3400
  • 20 % off
             
    $ 4700
  • 25 % off
         
    $ 6400
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
CALL OR EMAIL US
US:
India:
Email:
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Have a glance of the Report

  Download Free Sample

Looking for Customization?

 Customization Request

Have a Question?

 Reach Our Analysis Team

COVID-19 impact analysis?

 Request Analysis

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.

SPER-Astellas Pharma
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-IQVIA
SPER-Mitsubishi Logistics
SPER-PACCOR
SPER-Macmillan Education
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-SAPTCA
SPER-Straumann
SPER-MENARINI Silicon Biosystems
SPER-IPSOS
SPER-Heineken